![]() 2 Rybelsus is not recommended as first-line therapy for patients with type 2 diabetes rather, metformin is considered the preferred drug for initial treatment. 4 Semaglutide injectable (Ozempic) was approved in 2017 for patients with type 2 diabetes. 2,3 It is indicated for the treatment of type 2 diabetes, in combination with diet and exercise. Semaglutide (Rybelsus) was approved on September 20, 2019, as the first oral medication in the drug class glucagon-like peptide receptor agonist (GLP-1 RA), which is unique in its format-the other drugs in the class are injections. Pharmacists can assist with individualizing technology based on patients’ needs. ![]() ![]() According to the National Diabetes Statistics Report, 34.2 million Americans are living with diabetes. With new drugs and technologies available, pharmacists are at the forefront of the effort to educate patients and health care professionals about diabetes treatments, monitoring options, and pipeline drugs (see Table). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |